Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 13 | 2023 | 3143 | 1.650 |
Why?
|
| Kidney Neoplasms | 13 | 2023 | 4262 | 1.480 |
Why?
|
| Endogenous Retroviruses | 1 | 2022 | 112 | 0.770 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 146 | 0.680 |
Why?
|
| Neoplasms | 13 | 2023 | 21683 | 0.500 |
Why?
|
| Radiosurgery | 1 | 2023 | 1329 | 0.460 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2245 | 0.370 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2021 | 165 | 0.340 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13695 | 0.340 |
Why?
|
| Pandemics | 5 | 2022 | 8388 | 0.310 |
Why?
|
| Posture | 3 | 2020 | 958 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 2538 | 0.300 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.270 |
Why?
|
| Gait | 2 | 2020 | 793 | 0.240 |
Why?
|
| Scoliosis | 2 | 2020 | 725 | 0.220 |
Why?
|
| Spine | 2 | 2020 | 1144 | 0.220 |
Why?
|
| Walking | 2 | 2020 | 1180 | 0.220 |
Why?
|
| HLA-A3 Antigen | 1 | 2021 | 34 | 0.210 |
Why?
|
| Immunotherapy | 5 | 2023 | 4445 | 0.210 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2021 | 13 | 0.200 |
Why?
|
| Africa, Northern | 1 | 2021 | 82 | 0.190 |
Why?
|
| Bacteriuria | 1 | 2021 | 102 | 0.190 |
Why?
|
| Warts | 1 | 2021 | 68 | 0.190 |
Why?
|
| Middle East | 1 | 2021 | 219 | 0.180 |
Why?
|
| Lymphatic Diseases | 1 | 2022 | 324 | 0.180 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2019 | 12 | 0.180 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2022 | 252 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 315 | 0.170 |
Why?
|
| Pelvis | 2 | 2020 | 730 | 0.160 |
Why?
|
| Eye Neoplasms | 1 | 2020 | 313 | 0.160 |
Why?
|
| Acetanilides | 1 | 2019 | 168 | 0.160 |
Why?
|
| Humans | 44 | 2024 | 744343 | 0.160 |
Why?
|
| Kyphosis | 1 | 2020 | 237 | 0.150 |
Why?
|
| Liver Failure | 1 | 2018 | 241 | 0.140 |
Why?
|
| Postural Balance | 1 | 2020 | 620 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 788 | 0.130 |
Why?
|
| Drug Approval | 1 | 2021 | 742 | 0.120 |
Why?
|
| Photochemotherapy | 1 | 2021 | 807 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.120 |
Why?
|
| Urban Population | 1 | 2022 | 2021 | 0.110 |
Why?
|
| Melanoma | 2 | 2023 | 5510 | 0.110 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 1377 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2022 | 4217 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2023 | 4851 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 804 | 0.110 |
Why?
|
| Thiazoles | 1 | 2019 | 1483 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2023 | 3508 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2375 | 0.100 |
Why?
|
| Rural Population | 1 | 2022 | 2210 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1671 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 1199 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 4042 | 0.090 |
Why?
|
| Lebanon | 2 | 2021 | 229 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2020 | 2575 | 0.090 |
Why?
|
| Anilides | 2 | 2022 | 408 | 0.090 |
Why?
|
| Patient Selection | 1 | 2021 | 4215 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3610 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 1587 | 0.080 |
Why?
|
| Multiple Organ Failure | 2 | 2023 | 390 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13102 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3086 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 5853 | 0.070 |
Why?
|
| Retrospective Studies | 10 | 2023 | 77449 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2022 | 3309 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 20822 | 0.070 |
Why?
|
| Research Design | 1 | 2022 | 5987 | 0.070 |
Why?
|
| Mass Screening | 1 | 2021 | 5255 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9648 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5221 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12261 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2023 | 40561 | 0.060 |
Why?
|
| Female | 13 | 2024 | 380194 | 0.060 |
Why?
|
| Male | 12 | 2023 | 350118 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2022 | 142 | 0.050 |
Why?
|
| Lower Extremity | 2 | 2020 | 1158 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
| Tennessee | 1 | 2021 | 117 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 91 | 0.050 |
Why?
|
| Medical Oncology | 2 | 2024 | 2265 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5686 | 0.050 |
Why?
|
| Censuses | 1 | 2022 | 200 | 0.050 |
Why?
|
| Gentamicins | 1 | 2021 | 255 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2021 | 202 | 0.050 |
Why?
|
| Aminolevulinic Acid | 1 | 2021 | 142 | 0.050 |
Why?
|
| Cause of Death | 2 | 2022 | 3584 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2021 | 571 | 0.040 |
Why?
|
| Vaccination | 2 | 2021 | 3278 | 0.040 |
Why?
|
| Middle Aged | 9 | 2023 | 213383 | 0.040 |
Why?
|
| Aged | 8 | 2023 | 163280 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2022 | 371 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11124 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 552 | 0.040 |
Why?
|
| Calcaneus | 1 | 2020 | 138 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 676 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 491 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 841 | 0.040 |
Why?
|
| Genomics | 2 | 2024 | 5720 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2022 | 1915 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2021 | 602 | 0.040 |
Why?
|
| Health Facilities | 1 | 2022 | 573 | 0.040 |
Why?
|
| Foot | 1 | 2020 | 527 | 0.030 |
Why?
|
| Acetabulum | 1 | 2020 | 525 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 1821 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.030 |
Why?
|
| Adolescent | 5 | 2021 | 85781 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2018 | 424 | 0.030 |
Why?
|
| Risk Factors | 4 | 2022 | 72290 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10900 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2109 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1584 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2022 | 53288 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2020 | 1062 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2022 | 2038 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2569 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
| United States | 3 | 2023 | 69872 | 0.020 |
Why?
|
| Pyridines | 1 | 2022 | 2825 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 7023 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25043 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2022 | 3679 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 3923 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2018 | 3461 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8089 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 8428 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.020 |
Why?
|
| Cognition | 1 | 2022 | 6770 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15540 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29063 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29786 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 11727 | 0.010 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(65)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_